Members of the Notch family are involved in the development of breast cancer in animal models and in humans. In young transgenic mice, expressing intracellular activated Notch1 (N1 IC ) in mammary cells, we found that CD24 þ CD29 high progenitor cells had enhanced survival, and were expanded through a cyclin D1-dependent pathway. This expansion positively correlated with the later cyclin D1-dependent formation of basal-like ductal tumors. This expanded population exhibited abnormal differentiation skewed toward the basal cells, showed signs of pre-malignancy (low PTEN/p53 and high c-myc) and contained stem cells with impaired selfrenewal in vivo, and more numerous multipotent, ductalrestricted progenitors. Our data suggest that N1 IC can favor transformation of progenitor cells early in life through a cyclin D1-dependent pathway.
Introduction
The mammary gland is made up of differentiated epithelial cell types that can be distinguished by their cytokeratin (CK) staining: the ductal and alveolar luminal epithelial cells (CK8 þ , CK18 þ , CK19 þ ) constitute the inner layer, which is surrounded by basal or myoepithelial cells (CK14 þ ). The luminal and myoepithelial cell types originate from lineage-restricted progenitors, which are themselves produced by common multipotent epithelial progenitors enriched in the lineage-negative (Ter119
high cell subset Stingl et al., 2006) . Notch signaling is required for maintaining luminal cell fate and preventing uncontrolled basal cell proliferation (Buono et al., 2006; Bouras et al., 2008) . Notch3 was also found to be required for the differentiation of human bipotent progenitor cells to luminal lineage (Raouf et al., 2008) . The Notch pathway has been found to be deregulated in breast cancers (Callahan and Egan, 2004) . Notch4 and Notch1 are frequent targets of mouse mammary tumor virus (MMTV) provirus insertion in mouse mammary tumors, resulting in overexpression of mutant truncated intracellular forms of these proteins having transforming properties in vitro (Callahan and Egan, 2004) . Mouse IC activated Notch4 (N4 IC ) (reviewed in Callahan and Egan, 2004 ) and N1
IC (Hu et al., 2006) , and human N1 IC (Kiaris et al., 2004 ) also cause mammary tumors in transgenic (Tg) mice. Moreover, overexpression of Notch1 and Notch3 was documented in human breast tumors, and was associated with poor prognosis (Reedijk et al., 2005; Stylianou et al., 2006) . Conflicting results have been obtained on the effects of high Notch signaling in vitro. Enhanced Notch signaling achieved through exogenous ligands promoted human breast stem cell proliferation in mammospheres and affected their differentiation, in particular by increasing the number of myoepithelial progenitors (Dontu et al., 2004) . In contrast, short-term culture of mouse mammary stem/progenitor CD24 þ CD29 high cells in vitro, followed by their transduction with activated Notch1 led to their commitment to luminal cell fate after retransplantation in vivo (Bouras et al., 2008) .
It is not known whether breast stem/progenitor cells are themselves the target of oncogenic N1 IC in vivo. In the present study, we used the MMTV/N1 IC Tg mice expressing N1
IC and developing mammary tumors at high incidence (Hu et al., 2006) to gain insights into the mechanisms of Notch1-induced mammary tumors and to investigate the impact of N1 IC overexpression on mammary stem/progenitor cells in vivo.
Results

Expansion of the mammary CD24
þ CD29 high cells in MMTV/N1 IC Tg mice Similar to published data Stingl et al., 2006) , four distinct lineage-negative À (CD31 À CD45 À Ter119 À ) cell sub-populations could be detected by fluorescence-activated cell sorting in virgin non-Tg mammary glands, according to their expression of CD24 and CD29 ( Figure 1a ). In most MMTV/N1 IC Tg mice, the proportion of the CD24 þ CD29 high cell subset (R4), enriched for stem cells Stingl et al., 2006) , was significantly enhanced relative to nonTg mice (Figures 1a and b) . In contrast, none of the other well-defined Tg sub-populations (R1, R2, R3) showed differences in their proportion relative to nonTg ones (Figure 1b) . Quantitative RT-PCR expression analysis of cell-specific markers in these different sorted cell populations showed low levels of CK18 and ER-a in the R4 cell subset and their highest levels in R3 and R2 sub-populations, respectively (Supplementary Figure  S1) , consistent with published data (Asselin-Labat et al., 2006) . Comparable levels of CD24, CD29, SMA-a, K5, K14 and K18 were found in each Tg subset relative to the non-Tg one, except for K5 (highly enhanced in Tg R4) and K14 (slightly increased in R2; Supplementary Figure S1 ). In addition, ER-a was found to be moderately elevated in all these cell subsets. These findings suggest that the respective Tg and non-Tg cell subsets have conserved important features. However, the large increase of K5 in R4 CD24 þ CD29 high Tg cells indicates major changes in this population, which is enriched for stem cells (see below).
Absence of enhanced proliferation, but decreased apoptosis and lower PTEN and p53 expression in Tg CD24
þ CD29 high cells We tested whether the expansion of CD24 þ CD29 high cells in Tg mice results from their enhanced proliferation, using 5-bromo-2-deoxy-uridine (BrdU) labeling in vivo. The proportion of BrdU-positive cells, detected by immunohistochemistry with anti-BrdU antibody, was significantly decreased in the CD24 þ CD29 low Tg Figure 1 Expansion of mammary CD24 þ CD29 high stem/progenitor cells in N1 IC Tg mice is associated with decreased apoptosis and lower levels of PTEN and p53. (a, b) Fluorescence-activated cell sorting (FACS) analysis of freshly isolated mammary epithelial cells derived from a representative (a) and a group (b) of 8-week-old N1 IC Tg and non-Tg virgin FVB females. (c) Proliferation assay on 6-week-old virgin nonTg and Tg mice inoculated intraperitoneally with BrdU every other day for 2 weeks. BrdU-positive cells were detected among the indicated sorted purified mammary cell subsets by immunohistochemistry (IHC) with anti-BrdU antibodies. (d, e) Apoptosis assay. Mammary cells from 8-week-old virgin (d) or from 12-week-old involuting (e) (having given birth within 24 h and removed from their babies for 3 days) glands of N1 IC Tg and non-Tg mice were analyzed by FACS. Gated cell subsets were considered apoptotic if double positive for 7AAD and AnnexinV. (f, g) The RNA expression of p53 (f) or PTEN (g) in the four lineage-negative (lin À ) mammary cell subsets (shown in (a)) was performed by RT-PCR on cell-sorted purified cells. The quantification of the bands was assessed by ImageQuant (GE Healthcare Life Sciences, Baie d'Urfe, Quebec, Canada). Tg mice were regrouped according to the degree of expansion of the CD24 þ CD29 high cell subset: 1 Â ¼ no expansion; 2 Â or 3 Â ¼ expanded twofolds and threefolds, respectively. (h, i) The indicated cell subsets (50 000 cells) were purified by cell sorting and processed for western blot analysis with either anti-PTEN (h) or anti-p53 (i) antibodies. The membranes were then stripped and blotted with anti-actin antibody. Proteins were visualized by incubating the membranes with secondary antirabbit antibodies coupled to Alexa680 fluorochrome followed by scanning with Odyssey infrared imaging system (Licor, Licor Corporate Offices, Lincoln, NE, USA). The ratio of PTEN signal relative to that of actin was obtained. The number below each lane represents the semiquantitative values for the levels of expression relative to that in non-Tg CD24
À CD29 À cells (value of 1). (j) The expression of p53 protein was measured with anti-p53 antibody in the indicated lin À mammary cell subsets (shown in (a)) after stimulation with etoposide (10 mM) overnight.
Activated Notch1 in mammary stem/progenitor cells H Ling et al cell subset relative to that in the non-Tg one (Figure 1c ), but remained unchanged in the CD24 þ CD29 high Tg cell population ( Figure 1c ) as well as in the other two cell subsets (R1, R2; data not shown).
We then investigated whether the expansion of these Tg CD24 þ CD29 high cells reflects a lower rate of apoptosis. Apoptosis was measured using 7AAD/annexin V labeling by flow cytometry on CD24 þ CD29 low and CD24 þ CD29 high cell subsets from 8-week-old virgin and 3-day involuting mammary glands. The percentage of double-positive 7AAD þ /annexin V þ apoptotic cells of both populations was significantly decreased in virgin (Figure 1d ) as well as in involuting (Figure 1e ) Tg relative to non-Tg mammary glands.
As Notch signaling has been found to negatively regulate PTEN (Palomero et al., 2007) and p53 (Beverly et al., 2005) in T cells, and because loss of PTEN or p53 enhances cell survival (Brown and Wouters, 1999; Salmena et al., 2008) , we examined their expression in the four lineage-negative sorted cell subsets. p53 ( Figure 1f ) and PTEN ( Figure 1g ) RNA levels were significantly decreased in all populations, especially when expansion of CD24 þ CD29 high cells was more pronounced. This was also confirmed by quantitative RT-PCR for p53, which was detectable in all the four non-Tg cell populations (p53/S16 ¼ 0.8-0.87), but remained undetectable in all Tg samples despite easy detection of S16 (p53/S16o0.001). In addition, PTEN ( Figure 1h ) and p53 ( Figure 1i ) protein levels were also decreased in all Tg populations. Moreover, the enhanced expression of p53 protein observed in non-Tg CD24 þ CD29 low and CD24 þ CD29 high cells after stimulation with etoposide was not detected in the cell subsets from Tg mice (Figure 1j ). Consistent with low PTEN levels, p-AKT was markedly increased in Tg CD24 þ CD29 high cells (Supplementary Figure S2A) . Therefore, a significantly reduced rate of apoptosis, possibly mediated by decreased PTEN and p53 expression, is likely to explain the accumulation of Tg CD24 þ CD29 high cells in the absence of detectable proliferation.
The degree of Tg CD24 þ CD29 high cell expansion positively correlates with the levels of expression of N1 IC and its targets Immunostaining with antibodies against N1 IC showed that Notch expression was detectable at low levels in non-Tg CD24 þ CD29 high cells, and mostly outside the nucleus (Figure 2a ). However, a significant increase of N1 IC was found in both cytoplasm and nuclei of all examined Tg cells (Figure 2a) . By RT-PCR, N1
IC Tg RNA was also found to be expressed in all four cellsorted purified mammary cell sub-populations shown in Figure 1a (Figure 2b ). Interestingly, in CD24 þ CD29 high cells, the levels of Tg N1 IC RNA were higher when the mammary stem/progeny pool was itself more expanded (Figure 2c ), suggesting that the degree of mammary stem/progenitor expansion may be determined by the levels of N1 IC expression. In agreement with these results, the RNA expression of Notch1 downstream targets, Hes1, c-myc and cyclin D1 (Ronchini and Capobianco, 2001; Iso et al., 2003; Klinakis et al., 2006; Palomero et al., 2006; Weng et al., 2006) was also increased in Tg CD24 þ CD29 high cells relative to non-Tg ones, to levels positively correlating with the degree of their expansion (Figures 2d-f) . Cyclin D1 and c-myc, but not Hes1, RNA were also increased in the other Tg mammary epithelial sub-populations analyzed (Figures 2d-f) . Moreover, cyclin D1 protein expression was increased in all Tg cell subsets relative to non-Tg ones ( Figure 2g and Supplementary Figure S2B) .
þ CD29 high cell expansion in Tg mice deficient for cyclin D1 The enhanced cyclin D1 expression in the pre-malignant expanded CD24
þ CD29 high Tg mammary cell subset prompted us to examine whether its presence was necessary for their expansion. For this, the MMTV/ N1
IC Tg mice were bred on cyclin D1 gene-deficient background, and the mammary glands from 8-week-old virgin females were analyzed by fluorescence-activated cell sorting. Figure 3a ) and proliferated significantly more (threefold; Figure 3a ) than non-Tg cells. At 3 weeks, in contrast to the wellorganized, growth-arrested, polarized, duct-like, singlelayered non-Tg colonies (Figure 3b ), Tg colonies were disorganized, proliferative, multi-layered and nonpolar (Figure 3b ), indicating an impairment in differentiation. In some cases (seen in two out of six cultures, one culture per mouse), the paving-stone-like Tg cells were tightly arranged, piled up and formed nodules (Figure 3b ), suggesting a transformed state. Consistent with this hypothesis, these latter cultures originated from virgin females that were later found to develop mammary tumors 4 months earlier than the average latency for this group of mice.
Immunostaining of freshly plated CD24 þ CD29 high cells, while still positive for CD24 and CD29 (Figure 3c ), showed that a larger proportion of Tg (50-90%) than non-Tg (B10%) cells express higher levels of CK5 in early Tg cultures (Figure 3c ), suggesting the expansion of committed 'basal' progenitors within this cell subset. The 2D Tg cultures generated mainly Figure 3d ). In contrast, non-Tg 2D cultures predominantly generated CK14 þ , CK18 þ and CK14 þ CK18 þ , but no single CK5 þ colonies. These latter results indicated the presence of abnormal, but still multipotent Activated Notch1 in mammary stem/progenitor cells H Ling et al Tg progenitors able to differentiate into progeny with both myoepithelial and luminal characteristics.
Analysis of three-dimensional (3D) cultures after 7 weeks of incubation showed no colony formation with Tg or non-Tg CD24 high CD29 low (R3) cells in these conditions (data not shown), whereas Tg and non-Tg CD24 þ CD29 high (R4) cells gave rise to diverse structures (Figures 4a-c) . On the basis of their appearance and histological characteristics, the less complex colonies (types I-V) ( Figure 4a ) were common to non-Tg and Tg 3D cultures, and the most abundant type I colonies were more numerous in Tg than in non-Tg cultures (Table 1) (Table 1 and Figure 4c ). These latter colonies, which look transformed, were rare (two out of six cultures, one culture per mouse) and came from the same Tg mice whose CD24 þ CD29 high cells gave rise to paving-stone-like colonies in 2D cultures (discussed earlier) and were tumorigenic in vivo (see below Figure 6d ), strongly suggesting that the progenitors from which they originate are pre-malignant.
Together, these results strongly suggest the presence of enhanced numbers of pre-malignant, not fully committed progenitors with limited, but predominantly basal differentiation potential among the Tg CD24 þ CD29 high cell subset.
Abrogation of N1
IC -induced specific 3D colonies in the absence of cyclin D1 As cyclin D1 deficiency prevented expansion of CD24 þ CD29 high Tg cells in vivo, we also established 3D cultures with cyclin D1-deficient CD24 þ CD29 high cells. Fewer and smaller colonies of only three types (type I, II and IV) were generated from non-Tg cyclin
high cells (Table 1) . Interestingly, type III, V and VI colonies, all showing acinar features, were absent from cyclin D1 À/À cultures, consistent with the severe in vivo lobular defect observed in cyclin D1 À/À mice during pregnancy (Sicinski et al., 1995) . Despite the higher number of colonies in Tg cyclin D1 À/À cultures relative to non-Tg ones, the formation of disorganized type VII and VIII colonies by N1 IC -expressing Tg cells was, however, reduced in the absence of cyclin D1 (Table 1) . Unexpectedly, the inability of cyclin D1-deficient non-Tg cells to form branched type III and V colonies was rescued by Tg N1
IC showing CK labeling more similar to that of non-Tg colonies, although these structures remained smaller than in cyclin D1 þ / þ Tg mice (Figure 4d , Table 1 ).
Impaired self-renewal of N1
IC Tg stem/progenitor cells We next tested whether the differentiation potential and self-renewal of Tg CD24 þ CD29 high cells were also altered in vivo by performing serial transplantation into IC Tg mice were bred with the actin/GFP reporter mice for this experiment. At the first transplantation, the 1000 sorted CD24 þ CD29 high non-Tg cells gave rise to normalappearing glandular GFP þ outgrowths, consisting of ducts, branches and lobules within 8 weeks after transplantation in both Tg (data not shown) and nonTg (Figures 5a and b) hosts. However, the GFP þ glandular Tg structures were less numerous and showed abnormal features (enlarged primary ducts, reduced secondary and tertiary branching and lobules; Figures 5a and b) resembling those described previously in MMTV/N1 IC Tg mice (Hu et al., 2006) , indicating that the N1 IC -induced mammary gland developmental defects are cell autonomous. In addition, Tg progenitor cells showed higher seeding efficiency, as measured by an increase in number of poorly developed ducts or nodules (Figures 5b and c) . At the second and third passages, the number of Tg outgrowths was also higher than that of non-Tg ones, but these consisted of nodules or of primary ducts with minimal branching (Figures 5a  and b) . At each passage, the non-Tg glandular structures were made of the CK18 þ cells in the inner layer and of CK14 þ and a low number of CK5 þ cells in the outer layer (Figure 5c ). In contrast, Tg ductal-like structures showed increased number of CK5 þ cells and abnormal distribution of CK14 þ and CK18 þ cells, the inner CK18 þ cells were surrounded by CK14 (Figure 5c ), indicating that their precur- þ / þ mice taken at the same magnification, and the presence of type V colonies made of cells with similar cytokeratine-labeling to that of non-Tg specific structures. Activated Notch1 in mammary stem/progenitor cells H Ling et al sor(s) had retained the potential to differentiate into distinct lineages. These results show a severe impairment of the self-renewal potential of Tg CD24 þ CD29 high stem cells, and suggest the existence of a higher number of not fully committed progenitors with duct-restricted differentiation potential among this population, but still able to self-renew in vivo.
Mammary gland developmental defects and tumor formation correlate with the degree of expansion of mammary CD24 þ CD29 high cell sub-population We next used fluorescence-activated cell sorting analysis to assess the proportion of CD24 þ CD29 high cells in two mammary glands excised at an early age (8-week-old). These operated animals were then allowed to age to monitor the mammary gland developmental defects and the formation of tumors. Both the developmental defects (Supplementary Figure S3) , and the size and numbers of mammary tumors appearing late (Figure 6a ) positively correlated with the degree of early CD24 þ CD29 high cell expansion, suggesting a link between this expansion and tumor formation.
N1 IC -expressing early CD24
þ CD29 high Tg cells exhibit tumorigenic potential and are thus pre-malignant We next tested whether this Tg CD24 þ CD29 high cell population, recovered from young (8-week-old) Tg mice, was able to induce mammary tumors. Inoculation of 500 of these Tg cells into cleared mammary fat pads gave rise to mammary tumors after 6-15 months, at medium frequency, whereas non-Tg control cells did not (Figure 6b ). These tumors expressed high levels of CK5 and low levels of CK19 and were morphologically similar to those spontaneously arising in these MMTV/ N1 IC Tg mice (Figure 6c ). In contrast, transplantation of 50 000 pre-malignant CD24 þ CD29 low cells from 8-weekold Tg mice did not give rise to tumors nor to any structures (see above) in five inoculated fat pads tested (Figure 6b ). The tumorigenic potential of the disorganized type VIII or VII Tg colonies from 3D cultures was also assessed in vivo. After 10 months, these were found to induce small CK5-positive tumors, which showed signs of malignancy (mitotic figures, disorganization; Figure 6d ).
In view of the early loss of PTEN in Tg CD24 þ CD29 high cells, we measured its expression in N1 IC -induced tumors. PTEN expression was low, whereas the number pAKT-positive cells was increased in most tumors and their expression was negatively correlated (Supplementary Figure S4) .
Development of N1
IC -induced mammary tumors is prevented in the absence of cyclin D1 The required presence of cyclin D1 for the full expansion of the Tg CD24 þ CD29 high cell subset (Figure 2h ) and for the generation of type VII and VIII 3D Tg colonies ( Figure 4d , Table 1 ) prompted us to test whether cyclin D1 was also required for tumor development. Additional groups of N1 IC Tg mice were generated on cyclin D1 gene-deficient background and observed for tumor (Figure 7a ). In parous mice, these differences were less pronounced (Figure 7b ). However, both virgin and parous Cyl À/À N1 IC Tg mice were totally protected from tumor development (Figures 7a and b) , indicating that cyclin D1 is required for N1 IC -induced tumor development.
Discussion
Activated Notch1 impairs mammary stem cell selfrenewal and promotes the cyclin D1-mediated expansion of early duct-limited progenitors In this study, we have presented evidence that oncogenic Notch1 signaling favors the transformation of early multipotent mammary progenitor cells into pre-malignant cells through a cyclin D1-dependent pathway. The CD24 þ CD29 high cell subset, known to be enriched for early stem/progenitor cells Stingl et al., 2006) , was found to be significantly expanded in N1 IC Tg mice. Unexpectedly, increased proliferation of these Tg cells in vivo could not be documented. However, this population showed decreased apoptosis, suggesting that their enhanced survival may contribute to their expansion in vivo. A similar survival-promoting activity of N1 IC in other precursor cells has been reported (Oishi et al., 2004; Ciofani and Zuniga-Pflucker, 2005) . The lower levels of p53 expression and/or the enhanced PI3K/Akt pathway documented in CD24 þ CD29 high mammary cells is likely to enhance their resistance to apoptosis, as shown in other cell types transformed by activated Notch1 (Nair et al., 2003; Beverly et al., 2005; Mungamuri et al., 2006; Palomero et al., 2007) . Increased number of human (Dontu et al., 2004) or mouse (Bouras et al., 2008) breast stem/progenitor cells has previously been reported upon enhanced Notch signaling. However, in these in vitro manipulations with human breast cells, Notch signaling was induced with exogenous ligands, and the activity of individual Notch members on the phenotype was not studied (Dontu et al., 2004) . In addition, in Bouras et al.'s experiments (Bouras et al., 2008) , mouse mammary stem/progenitor cells Activated Notch1 in mammary stem/progenitor cells H Ling et al Figure 6 The CD24 þ CD29 high N1 IC Tg cells exhibit oncogenic potential. (a) Extent of early Tg CD24 þ CD29 high cell expansion and late tumor incidence. Two mammary glands were excised from each 8-week-old virgin females and assessed by FACS analysis for the degree of CD24 þ CD29 high cell expansion as shown in Figure 1a . The animals were allowed to age and monitored between 6-15 months of age for mammary tumor formation macroscopically and in wholemount. IC in vitro, leading to expansion of only committed luminal progenitor cells after transplantation in vivo, in contrast to the expansion of earlier common progenitors (see below) reported in this study, when N1 IC is expressed in vivo. Displacement from their natural niche and incubation in vitro may have affected the distribution and properties of these progenitors. Thus, our results extend earlier in vitro data by showing that activated Notch1 has a positive effect on the number of mouse mammary stem/progenitor cells in vivo.
The expanded CD24 þ CD29 high Tg cell sub-population contains the rare genuine stem cells capable of generating complete ducto-lobular glandular outgrowths. These, which may or may not be expanded, exhibit a severely decreased in vivo self-renewal capacity, possibly because of low PTEN. PTEN is indeed known to be required to maintain self-renewal of other (hematopoietic) stem cells (Yilmaz et al., 2006; Zhang et al., 2006) . However, another CD24
þ CD29 high progenitor cell subset with unique characteristics accumulates in N1 IC Tg mice. These progenitors were found to be multipotent in vivo and in vitro, and capable of basal and luminal differentiation. They were also still capable of self-renewal in vivo. However, their progeny outgrowths after transplantation into cleared fat pads were small and consisted mainly of CK5 þ CK14 þ CK18 þ primitive ducts or nodules, clearly indicating they did not originate from stem cells capable of full ductolobular development. Rather, these Tg progenitors, although still capable of basal and luminal commitment, seem to have limited development potential and are likely to represent duct-limited progenitors described previously (Smith and Medina, 2008) . Therefore, N1 IC overexpression seems to have a more negative impact on self-renewal of stem cells with full ductolobular potential than on progenitors with duct-limited potential.
In search for factors that may contribute to the expansion of Tg CD24 þ CD29 high cells, we found enhanced cyclin D1 levels, a result compatible with its promoter being a direct target of CBF-1 (Ronchini and Capobianco, 2001) . Evidence that cyclin D1 was required for this enhanced in vivo accumulation was provided by its deletion, which significantly abrogated the N1 IC -induced in vivo expansion of CD24 þ CD29 high cells (a cell population showing normal BrdU incorporation and lower apoptosis). Interestingly, deletion of cyclin D1 also reduced the number of Tg-specific type VII þ VIII disorganized in vitro structures. These results indicate that cyclin D1 is required for these in vivo and in vitro phenotypes. Cyclin D1 is frequently overexpressed in various tumors, including in breast cancers, and is best known for controlling G1/S transition during the cell cycle (Massague, 2004) . However, it can also mediate resistance to apoptosis in some cells in the absence of cell-cycle regulation (Ahmed et al., 2008; Roue et al., 2008 ). It appears that cyclin D1 can promote survival of CD24 þ CD29 high Tg progenitor cells in vivo, but further experiments will be necessary to assess the relative contribution of the pro-survival and pro-growth functions of cyclin D1 in mammary stem/ progenitor cells.
In non-Tg cyclin D1 KO virgin mice, the number of the CD24 þ CD29 high cells was comparable to that in nonTg wild-type mice, consistent with the normal mammary gland development in virgin cyclin D1 À/À mice (Sicinski et al., 1995; Yu et al., 2001) . Thus, our results indicate that accumulation of normal and N1 IC -expressing premalignant mammary progenitor cells can be distinguished molecularly, that is, respectively by their dependence or not on cyclin D1. To our knowledge, this is the first time that cyclin D1 is shown to be essential for the execution of the N1
IC signal in such a primitive stem/progenitor cell population having all the characteristics of pre-malignant cells (see below). Tg cells represent apparently unstable, pre-malignant progenitor cells. They show high c-myc levels and lower expression of PTEN and p53, all changes predisposing to mammary tumor formation. Their progeny proliferate in vitro at a higher rate than non-Tg cells. They give rise in vitro to highly disorganized proliferative colonies (types VII þ VIII) reminiscent of transformed cells, suggesting that they may be genetically unstable under certain conditions, such as incubation in vitro. Inoculation of these cells or of type VII or VIII disorganized nodules derived from them give rise to mammary tumors. Their early expansion correlates closely with later tumor formation, and abrogation of this early expansion in cyclin D1-deficient mice also correlates with the absence of tumors in these KO mice. This latter result extends a previous report showing that in vitro transformation of RKE-1 cells by N1 IC requires cyclin D1 (Stahl et al., 2006) .
The differentiation of CD24 þ CD29 high Tg cells is also abnormal, giving rise to CK5 þ cells at a much greater frequency than non-Tg cells and generating dysplasic outgrowths in vivo. Finally, similar to the mixed colonies generated from these CD24 þ CD29 high Tg cells in 2D or 3D cultures, they give rise to ductal tumors of mixed lineage composition (CK5 þ , CK18 þ ). Our data suggest that mammary tumors arise in N1 IC Tg mice from the expansion of uncommitted progenitor cells either of limited potential (such as duct limited (Smith and Medina, 2008) ) or blocked in their full differentiation potential and most likely having accumulated additional mutations.
The mammary tumors in N1 IC Tg mice show many similarities with the human basal breast carcinoma despite controversies in classifying such tumors (Gusterson, 2009 ). These human tumors are characterized by high number of CK5-and CK14-positive cells, early loss of p53 and PTEN expression, activated PI3K pathway, resistance to apoptosis, high Notch and c-myc levels, and loss of estrogen receptors (Sorlie et al., 2001; Lee et al., 2008; Marty et al., 2008; Saal et al., 2008; Gusterson, 2009 (Saal et al., 2008) , and as enhanced Notch expression also appears to be the hallmark of these tumors (Lee et al., 2008) , the MMTV/ N1 IC Tg mice may represent a valid model for this human disease. In human, early events in life, at a time when expansion of stem/progenitor cells occurs, have also long been known to represent major predisposing factors for breast cancer (Michels and Willett, 2004) . The early expansion of CD24 þ CD29 high progenitor cells in the MMTV/N1
IC Tg mice and the subsequent associated enhanced tumor formation may recapitulate similar events in humans and represent a relevant model for this long-standing epidemiological observation in women.
Materials and methods
Mice
The MMTV/N1 IC Tg (Hu et al., 2006) and cyclin D1 KO (Sicinski et al., 1995) mice were described previously. N1
IC Tg mice were bred on the FVB background (for at least six generations) for all experiments, except when bred with the cyclin D1 KO mice, wherein both strains were on the outbred CD1 background. The FVB, cyclin D1 KO (# 002537) and actin/GFP Tg mice (# 003516) were obtained from the Jackson Laboratory, Bar Harbor, ME, USA.
Mammary cell preparation and flow cytometry
The # 4 inguinal mammary glands were dissected from 8-weekold virgin female Notch Tg or non-Tg mice and prepared for flow cytometry, and sorting essentially as described previously Stingl et al., 2006) .
Immunofluorescence staining
Staining was performed as described previously (Hu et al., 2006) . BrdU labeling is detailed in the Supplementary Information.
Mammary fat pad transplantation and analysis
The transplantation technique has been described previously (DeOme et al., 1959) . Sorted cells were resuspended in the culture medium and injected in 10 ml volumes into the surgically cleared fat pad of inguinal glands of 3-week-old females.
RT-PCR analysis
Total RNA were extracted from 10 000 sorted cells following the extraction protocol provided by Qiagen mini RNA extraction kit (Qiagen, Mississauga, ON, Canada). RT-PCR and quantitative RT-PCR was performed as described previously (Hanna et al., 2009) .
Differentiating culture conditions
Single cell suspensions of 1000 sorted cells were plated on Matrigel-coated 6-cm-diameter petri dishes (2D) or embedded in 2 ml of semisolid 1:5 Matrigel (Stem Cell Technology, Vancouver, BC, Canada), as detailed in the Supplementary Information.
Statistical analysis
Statistical analyses were performed with the Student's t-test (means ± s.d.), except for data shown in Figure 6a and Figure 7 wherein respectively the chi-square test on two unequal variances and the log rank (Kaplan-Meier) test were used.
